(From Poz Magazine)
An analysis of 32 studies of Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) found that almost all of those who contracted HIV had undetectable or very low levels of the drug in their bodies at the time. Researchers from Gilead Sciences, Truvada’s manufacturer, presented the findings from their analysis of these studies at the ASM Microbe 2016 conference in Boston.
The investigators in the trials conducted dried blood spot tests on participants to determine levels of tenofovir in specific blood cells at the time they contracted HIV. These tests can detect adherence to Truvada with a window looking back about eight weeks.
The Georgia AIDS and STI Information Lineis a free service, providing confidential and anonymous answersand referrals to questions concerning testing, treatment, PrEP,risk assessment, safer sex practices, case management, social services, emotional wellness counseling, and medication assistance for personsinfected or affected by HIV and STIs.
Para cualquier preguntas en Español, tenemos el personal de Lunes a Viernes de 9:00am-1:00pm.
1-800-551-2728 or 404-876-9944Hours: Monday – Thursday 9am-9pm, Friday 9am–7pm.
Join us for the 26th annual AIDS Walk Atlanta & 5K Run on Sunday, October 16, 2016! This year, more than ever before, your participation as a walker, runner, or volunteer will make a significant difference in the lives of people living with and at-risk for HIV/AIDS in Atlanta!
With the 5th highest number of AIDS cases in the country we welcome participants as walkers, runners, and crew members to help address Metropolitan Atlanta’s AIDS crisis.
All individuals who wish to participate are required to register.
General Information: (404) 870-7700STI Testing: (404) 870-7722Volunteer: (404) 870-7764Comment Line: (678) 999-1212(Anonymous)
1605 Peachtree Street NE, Atlanta, GA 30309-2955(404) 870-7700
This web site contains HIV prevention information and may not be suitable for all audiences.